A Case Report of Clinical Remission of Multiple Myeloma with Yoga Prana Vidya Healing as complementary therapy

Authors

  • Anvita Bhatt, Mohini Yagnik, Venkata Satyanarayana Nanduri Author

DOI:

https://doi.org/10.66838/

Keywords:

Multiple Myeloma, Igg Kappa, Yoga Prana Vidya System ®, Ypv ®, Complementary Therapy,

Abstract

Background: Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation, paraprotein secretion, and end organ damage. Despite advances in chemotherapy and immunotherapy, relapse and immune suppression remain challenges.

Case Presentation: A 64 year old male physician diagnosed with IgG kappa myeloma in December 2025 presented with shoulder pain, back pain, and breathlessness. He received oral and injectable chemotherapy for four months. Concurrently, daily Yoga Prana Vidya (YPV) healing sessions (30 minutes morning and evening) were administered for four months.

Results: Serial biomarkers showed dramatic decline in free kappa light chains (642.4 → 4.6 mg/L), normalization of kappa/lambda ratio (28.67 → 0.75), LDH reduction (378 → 203 U/L), and clearance of monoclonal protein by April 2026. Clinically, the patient resumed professional duties by the third month. Reports dated 19 April 2026 confirmed remission, though hypogammaglobulinemia persisted.(22-23)

Discussion: Literature supports multimodal management of myeloma, with YPV offering adjunctive benefits in stress reduction, autonomic regulation, and immune modulation. This case highlights synergistic outcomes of conventional therapy and YPV healing.

Conclusion: YPV healing may serve as a safe, cost effective complementary therapy in myeloma management, warranting further controlled studies.

Downloads

Published

2026-06-28

How to Cite

A Case Report of Clinical Remission of Multiple Myeloma with Yoga Prana Vidya Healing as complementary therapy. (2026). Journal of Carcinogenesis, 25(1), 495-499. https://doi.org/10.66838/

Similar Articles

21-30 of 542

You may also start an advanced similarity search for this article.